PACS 2025 presentation: 29% revenue surge, 81% EBITDA jump
Core inflation in Japan’s capital slows, falling below central bank’s 2% target
Vertex Pharma EVP McKechnie sells $2.39m in shares
Oportun Q4 2025 slides: profitability surge masks modest EPS miss
Earnings call transcript: Sprout Social beats Q4 2025 forecasts
Health care spending is surging just as Trump’s tax cuts crippled its funding
Latest articles
Popular articles
Featured
Newsletter
Subscribe to get the latest news, offers and special announcements.


